HARNESS THERAPEUTICS LIMITED
HARNESS THERAPEUTICS LIMITED is a private limited company registered in the United Kingdom, under 11532498, incorporated on 22 August 2018. The company is currently active. Operates in the research and experimental development on biotechnology sector (SIC 72110). The company has been operating for 7 years. Registered office address: CB22 3AT Cambridge, the United Kingdom. Formerly known as TRANSINE THERAPEUTICS LIMITED. Directors include DR PAULO FONTOURA, DR JIAPING GU, and DR CHRISTIAN BILLY JUNG, and 2 others. Shareholders include Takeda Pharmaceutical Company Limited and DEMENTIA DISCOVERY GP LP. Associated with 11 related entities, including PLATFORM STRATEGY CONSULTING LIMITED, TAKEDA CAMBRIDGE LIMITED, and DDF PARALLEL LLP. No sanctions, PEP status, or adverse risk signals are currently on record. Data sourced from UK Companies House.
Official Identifiers
Name Registry
TRANSINE THERAPEUTICS LIMITED
Registered Address
MINERVA BUILDING (B250)
BABRAHAM RESEARCH CAMPUS
CB22 3AT CAMBRIDGE
the United Kingdom
Signal Intelligence
No sanctions, PEP status, or adverse risk signals are currently on record for this entity.
Key Management & Controllers
Associated Entities
Companies sharing one or more directors or officers with this entity.
Source Records (1)
| companieshouse | 11532498 | 2026-06-01 | open_in_new |